Evolution of IL-23 Blockade in Inflammatory Bowel Disease

被引：2
|
作者：
Danese, Silvio [1 ,2 ]
Peyrin-Biroulet, Laurent [3 ,4 ]
机构：
[1] IRCCS San Raffaele, Gastroenterol & Endoscopy, Via Olgettina 60, I-20132 Milan, Italy
[2] Univ Vita Salute, Via Olgettina 60, I-20132 Milan, Italy
[3] Lorraine Univ, Dept Hepato Gastroenterol, Vandoeuvre Les Nancy, France
[4] Lorraine Univ, INSERM, U1256, Univ Hosp Nancy, Vandoeuvre Les Nancy, France
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷 / SUPPL 2期
关键词：
IBD;
D O I：
10.1093/ecco-jcc/jjab188
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Serum IL-17 and IL-23 levels can distinguish between severe and non-severe inflammatory bowel disease
    Lucaciu, L.
    Ilies, M.
    Iuga, C.
    Seicean, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S163 - S163
  • [42] Inducible nitric oxide synthase is upregulated by IL-23/IL-17A axis in inflammatory bowel disease: A study in Algerian patients
    Rafa, Hayet
    Saoula, Houria
    Belkhelfa, Mourad
    Medjeber, Oussama
    Soufli, Imene
    Toumi, Ryma
    de Launoit, Yvan
    Morales, Olivier
    Nakmouche, M'hamed
    Delhem, Nadira
    Boukoffa, Chafia Touil
    CYTOKINE, 2013, 63 (03) : 291 - 291
  • [43] IL-23/IL-17A Axis Correlates with the Nitric Oxide Pathway in Inflammatory Bowel Disease: Immunomodulatory Effect of Retinoic Acid
    Rafa, Hayet
    Saoula, Houria
    Belkhelfa, Mourad
    Medjeber, Oussama
    Soufli, Imene
    Toumi, Ryma
    de Launoit, Yvan
    Morales, Olivier
    Nakmouche, M'hamed
    Delhem, Nadira
    Touil-Boukoffa, Chafia
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2013, 33 (07): : 355 - 368
  • [44] The role of IL-23 in joint disease
    Schett, Georg
    RHEUMATOLOGY, 2021, 60 (11) : 5486 - 5487
  • [45] The IL-23–IL-17 axis in inflammatory arthritis
    Erik Lubberts
    Nature Reviews Rheumatology, 2015, 11 : 415 - 429
  • [46] Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease
    Roberts, Kevin J.
    Cubitt, Marion F.
    Carlton, Timothy M.
    Rodrigues-Duarte, Lurdes
    Maggiore, Luana
    Chai, Ray
    Clare, Simon
    Harcourt, Katherine
    MacDonald, Thomas T.
    Ray, Keith P.
    Vossenkamper, Anna
    West, Michael R.
    Crowe, J. Scott
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [47] Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease
    Kevin J. Roberts
    Marion F. Cubitt
    Timothy M. Carlton
    Lurdes Rodrigues-Duarte
    Luana Maggiore
    Ray Chai
    Simon Clare
    Katherine Harcourt
    Thomas T. MacDonald
    Keith P. Ray
    Anna Vossenkämper
    Michael R. West
    J. Scott Crowe
    Scientific Reports, 11
  • [48] A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases
    Verstockt, Bram
    Deleenheer, Barbara
    Van Assche, Gert
    Vermeire, Severine
    Ferrante, Marc
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (07) : 809 - 821
  • [49] Interleukin (IL)-23 Suppresses IL-10 in Inflammatory Bowel Disease
    Liu, Zhanju
    Feng, Bai-Sui
    Yang, Shao-Bo
    Chen, Xiao
    Su, Jingling
    Yang, Ping-Chang
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (05) : 3591 - 3597
  • [50] THE ROLE OF IL-17, IL-23 SERUM LEVELS IN PATIENTS WITH ANKYLOSING SPONDYLITIS WITH INFLAMMATORY BOWEL DISEASES
    Lukina, G.
    Kulakova, P.
    Alexandrova, E.
    Novikov, A.
    Savenkova, N.
    Klimets, A.
    Kartushina, I.
    Kovshik, A.
    Volnukhin, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1551 - 1551
12345